Home · Solutions

The world’s first MDR-approved AI-solution to improve diagnosis of pancreatic lesions

Non-invasive screening algorithm that anticipates pancreatic, hepatic, and renal cancer by detecting & identifying focal lesions, automating their monitoring.

Sensitivity in Lesions Detection

96,3%

Standard of care surpassed: 96,3% sensitivity & 84,5% specificity**

Proven Technical Feasibility

8 Hospitals

  • Proven as plug & play product in several PACS
  • Patented internationally for pancreas (WO 2023/030734)

100%

detection of benign lesions ending up in cancer *

We operate across three key organs

Product Features

Fully integrable in current workflow
SYCAI MEDICAL works as an AI-based silent assistant providing the latests technological advances to the radiologists without impacting their workflow.
We have the only patent that enables an automatic single-lesion tracking over time, saving time to radiologists and presenting the results in a standardized way
As an ISO 13485 certified company and CE Marked as class IIb we assure full safety on GDPR, cybersecurity and patient impact.
The current platform conception of SYCAI MEDICAL allows us to enable key features to expand to other organs and pathologies on each product updates, offering our current customers a wider range of patients to benefit from the tool

We are CE-Marked

Quality assured solution by ISO 13485 certification

Testimonials